Aegis Capital Starts Oramed Pharma (ORMP) at Buy, PT $25
Tweet Send to a Friend
Aegis Capital initiated coverage on Oramed Pharma (NASDAQ: ORMP) with a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
